Chemocessories Gives Cancer Patients a Colorful BoostInside the heart of Chemocessories, a nonprofit that donatesmatching hair wraps and jewelry to...Pegher, Kelcie
[18].Mathis SE,et al. Chemo-predictive assay for targeting cancer stem-like cells in patients affected by brain tumors. PLoS One. 2014 Aug 21;9(8):e105710. [19].Howard CM,et al. Clinical relevance of cancer stem cell chem...
Whilst the focus of oncological care continues to be on cure, there is a growing need of recognition that for many patients, cancer has become a chronic disease; the paradigm must shift from illness to optimum wellness. Management of long-term chemotherapy-related toxicity involves screening for ...
[9] Li J, Qin S, Xu RH, Shen L, Xu J, Bai Y, et al. Effect of Fruquintinib vs Placebo on Overall Survival in Patients With Previously Treated Metastatic Colorectal Cancer: The FRESCO Randomized Clinical Trial. Jama. 2018;319(24...
Carol Kwok, who led the study, said that pre-surgery chemotherapy may bring "new hopes" for breast cancer patients as a higher pathological complete response (PCR) rate was observed in some aggressive tumor types such as the HER2-positive and the triple-negative breast cancers. ...
The combination of nivolumab plus ipilimumab is now approved as first-line treatment for patients with metastatic non-small-cell lung cancer.
In terms of other treatments, 31% of UK oesophageal cancer patients received radiotherapy compared to 59%, 53% and 54% respectively for the other countries. While the five-year survival rate of stage three colon cancer patients in the UK is at 63%, Canada and Australia are at 70...
[5].Fukuoka S,Hara H,Takahashi N,et al.Regorafenib Plus Nivolumab in Patients With Advanced Gastric or Colorectal Cancer:An Open-Label,Dose-Escalation,and Dose-Expansion Phase Ib Trial(REGONIVO,EPOC1603).J Clin Oncol.2020;38(18):2053-2061. ...
Background: Definitive (chemo)radiation as primary treatment modality is offered to esophageal cancer (EC) patients, as an alternative for patients considered medically unfit for surgery or having irresectable tumors. We evaluated the results in our cohort to improve selection of patients for intensifi...
“more an investigation into how we can best help black patients throughout the process of cancer treatment to try to address these disparities.” the research is scheduled for presentation friday at an american college of cardiology conference in washington, d.c. findings pres...